Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sharlène Côté"'
Autor:
Mathieu Dallaire, Alexandra Houde-Thibeault, Jérôme Bouchard-Tremblay, Enafa Anais Wotto, Sharlène Côté, Claudia Santos Oliveira, Suzy Ngomo, Rubens A. da Silva
Publikováno v:
Experimental Gerontology, Vol 186, Iss , Pp 112360- (2024)
Background: Parkinson's Disease (PD), a neurodegenerative condition, affects normal aging and leads to reduced motor abilities. In addition, frailty syndrome can increase vulnerability and risks of undesirable effects such as disease progression, fal
Externí odkaz:
https://doaj.org/article/02697bcb624947f09af4a204f0d7c2c1
Autor:
Mathieu Dallaire, Guillaume Gagnon, Émilie Fortin, Josée Nepton, Anne-France Severn, Sharlène Côté, Suhaila Mahmoud Smaili, Hayslenne Andressa Gonçalves de Oliveira Araújo, Márcio Rogério de Oliveira, Suzy Ngomo, Julie Bouchard, Rubens A. da Silva
Publikováno v:
Geriatrics, Vol 6, Iss 4, p 105 (2021)
Introduction: Parkinson’s disease is most prevalent among elderly people, 65 years and over, and leads to an alteration in motor control associated with postural instability. Current evidence shows that postural control decreases with the aging pro
Externí odkaz:
https://doaj.org/article/ff8d051424344648a714cb87711bc483
Publikováno v:
The Annals of pharmacotherapy. 51(2)
Background: There are few studies of the association between the use of antioxidant vitamin supplements and the risk of Alzheimer’s disease (AD). Cognitive decline is generally viewed as part of the continuum between normal aging and AD. Objective:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85842c0dc6e2536ff8f14ba59cecda43
https://pubmed.ncbi.nlm.nih.gov/27708183
https://pubmed.ncbi.nlm.nih.gov/27708183
Nonsteroidal anti‐inflammatory drug use and the risk of cognitive impairment and Alzheimer's disease
Autor:
Pierre-Hugues Carmichael, Joan Lindsay, Sharlène Côté, Jean Lefebvre, Danielle Laurin, René Verreault
Publikováno v:
Alzheimer's & Dementia. 8:219-226
Background Some observational studies have established an association between exposure to nonsteroidal anti-inflammatory drugs (NSAIDs) and a decreased risk of subsequently developing Alzheimer's disease (AD). Mild cognitive impairment or cognitive i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64f4ed873f133e0f59abdfbef3ee80e6
https://doi.org/10.1016/j.jalz.2011.03.012
https://doi.org/10.1016/j.jalz.2011.03.012